Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.Get notified
← All analysis
WAITMEDIUM confidence

A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.

ServiceNow, Inc. (NOW)

NYSE · Enterprise Software (SaaS) · 2026-06-06 · analysis, not advice

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 112.45 (as of 2026-06-06)

The panel is united on the business and divided only on the price. Nearly every framework calls ServiceNow one of the highest-quality enterprise software franchises in the world — 98% renewals, ~35–44% free-cash-flow margins, 22% growth — yet the stock sits ~47% below its post-split high. No one argues the franchise is broken; the cautious voices simply want a better entry, which is what tips the synthesized read to WAIT rather than a clear edge in either direction.

Key levels

Level
Resistance R3 / R2 / R1 USD 165 / 150 / 130
Current price USD 112.45
Support S1 / S2 / S3 USD 108 / 98 / 88
Analyst consensus target USD 123 – 142 – 260

Key resistance sits at the ~$130 zone (where a Supertrend flip and the recent failed spike to $139 align) up through historical resistance near $150 and $165; key support runs from the 5-week moving-average area near $108 down to a historical accumulation zone around $85–92, and the analyst consensus target spans roughly USD 123 to 260 with an average near USD 142.

What legendary investors think

We ran ServiceNow past a panel of six legendary investors' frameworks.

Investor Lens Signal Conviction The case in their words
Philip Fisher Growth (quality) Bullish High Scores 14/15 on the checklist — Now Assist AI ACV went $0→$750M in under two years, 44% Q1 FCF margin, zero structural debt issues; an exceptional business whose only question is entry price at ~55x forward.
Cathie Wood Growth Bullish High ServiceNow is the neutral orchestration/governance layer for enterprise agentic AI (AI Control Tower) across a TAM heading to $500B+; cRPO +22.5% shows demand accelerating even as the stock fell ~47%.
Bill Ackman Quality/Value Bullish Med-High A wide-moat compounder (98% renewals, 120%+ NRR) generating ~$4.6B FCF, now at ~21x forward FCF vs 45–50x at peak — the most attractive entry in 3+ years; intrinsic value ~$140–165.
Warren Buffett Value Neutral Medium A genuinely wonderful franchise (98% renewals, 35% FCF margin), but at ~70x trailing / ~24–25x forward earnings there's no margin of safety; would buy with conviction nearer $85–95.
Peter Lynch Growth (GARP) Neutral Medium A "Fast Grower" with a non-GAAP PEG ~1.2–1.3, but the Armis deal added near-term debt and the GAAP picture (~70x) is expensive; reasonable, not a bargain, until the high-$80s.
Aswath Damodaran Valuation Bearish Medium On owner-earnings DCF that treats ~$2B+ annual stock-comp as a real cost, base fair value is ~$78; at $112 the bull case is already priced in. Interested at $80–85.

Where they agree — and where they clash

Common ground

  • The business quality is exceptional and largely undisputed: 98% renewal rate, 120%+ net revenue retention, ~35–44% FCF margin, 22% revenue growth on a ~$14B base.
  • The moat is deep — workflow embeddedness across IT/HR/security/finance creates near-irreplaceable switching costs.
  • The ~47% drawdown was driven mostly by sentiment (AI-cannibalization "SaaSpocalypse" fears, Armis margin headwinds, macro rates) rather than a break in fundamentals.

The real debate

  • Stock-based comp: Damodaran treats ~$2B+ of annual SBC as a real cost and lands at ~$78 fair value, while Fisher, Wood, and Ackman lean on the ~32% non-GAAP margin and ~21x forward FCF to call it cheap.
  • Entry now vs. lower: Ackman and the fundamentals see ~21x forward FCF on a 25%-compounding cash engine as a generational entry, whereas Buffett and Lynch want the high-$80s/low-$90s for a genuine margin of safety.
  • Business vs. chart: The fundamental case is constructive, but the technical picture is a Stage 4 downtrend with a failed breakout at ~$130 on heavy distribution volume — quality versus a broken tape.

The question it comes down to: Is ServiceNow's ~47% de-rating a sentiment-driven mispricing of a wonderful compounder — or is a still-rich ~70x trailing multiple with a Stage 4 chart telling you the lower entry the valuation hawks want is still ahead?

The numbers

Metric Value
Price / Market cap USD 112.45 / ~116B
P/E (TTM / fwd) ~66–70x / ~28x
ROE 13.5%
Operating margin ~13.5% GAAP (~32% non-GAAP)
Dividend yield 0% (no dividend)
Debt / equity 0.21
Free cash flow USD 1.67B (Q1 2026, 44% margin); 4.58B (FY2025)

Figures as of Q1 2026 / June 2026; sourced from ServiceNow IR/SEC filings, GuruFocus, MacroTrends, StockAnalysis.

The bottom line

The tension is narrow: a business almost no one doubts at a price almost no one agrees on. ServiceNow compounds free cash flow at 25%+ from a dominant, deeply embedded enterprise platform, and its ~47% fall from the high — largely a sentiment story around AI cannibalization fears and Armis integration costs — has pulled the forward cash-flow multiple to its lowest in years, which is why three of six legends and the fundamental read see opportunity. What argues for patience is equally concrete: on owner-earnings that count heavy stock-comp the stock can look fully valued near $78–95, and the chart is in a confirmed downtrend that just rejected hard at $130 on record volume. Because the whole panel likes the franchise and the only real dispute is entry price — with a clear lower-price level and a dated catalyst pending — the debate resolves to one about timing, not merit. What would tip it bullish is Armis integrating cleanly with FY2027 margin recovery on track and Now Assist AI ACV scaling past its $1.5B target, or a reclaim of $130; what would tip it bearish is renewals slipping below 95%, growth decelerating under ~18%, or support at $85–92 failing. The next binary is Q2 earnings in late July.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Get notified of new analysis

Tell us which stocks you want the panel to cover. We'll email you when the analysis is live.

No spam. Unsubscribe anytime.